Effect of repeat prostate biopsies on functional outcomes after radical pro statectomy

被引:3
|
作者
Rosenbaum, Clemens M. [1 ,2 ]
Mandel, Philipp [1 ,2 ]
Tennstedt, Pierre [1 ]
Preisser, Felix [1 ]
Marks, Phillip [1 ,2 ]
Chun, Felix K. -H. [1 ,2 ]
Graefen, Markus [1 ]
Tilki, Derya [1 ,2 ]
Salomon, Georg [1 ]
机构
[1] Univ Hosp Hamburg Eppendolf, Martini Klin Prostate Canc Ctr, Hamburg, Germany
[2] Univ Hosp Hamburg Eppendolf, Dept Urol, Hamburg, Germany
关键词
Active surveillance; Functional outcome; Prostate cancer; Radical prostatectomy; Repeat prostate biopsy; ACTIVE SURVEILLANCE; ERECTILE FUNCTION; CANCER; IMPACT; MEN; URINARY; COHORT; INCREASE; TRENDS; RISK;
D O I
10.1016/j.urolonc.2017.11.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Growing acceptance of active surveillance (AS) results in a relevant number of patients who will undergo radical prostatectomy (RP) after multiple biopsy sessions (Bx) due to cancer progression. The effect of repeat Bx on functional outcomes after RP remains controversial. Methods: Overall, 11,140 patients who underwent RP from 2007 to 2015 were analyzed. Number of Bx sessions (1 vs. 2 vs. >= 3) before RP was examined. Association between number of Bx sessions and erectile dysfunction (ED) and urinary incontinence (UI) was assessed by univariable and multivariable logistic regressions. Results: A total of 9,797 (87.9%) had 1 Bx, 937 (8.4%) had 2 Bx, and 406 (3.6%) had 3 or more Bx. Median age was 65 years (IQR: 5969). Increasing Bx sessions were associated with advanced age at surgery (1, 2, and >= 3 Bx: 65, 65, and 67 years, P < 0.001); 982 (45.9%), 906 (57.9%), and 597 (60.9%) patients achieved potency at 1, 2, and 3 years after RP, respectively. On adjusted analysis repeat Bx compared to initial Bx had no influence on ED at 1, 2, and 3 years. At 1, 2, and 3 years after RP, 6,107 (87.9%), 4,825 (90.9%), and 3,696 (91.6%) patients achieved continence. Number of Bx session had no influence on UI at follow up. Conclusion: Our findings demonstrate that ED and UI rates are comparable among patients undergoing RP after initial and repeat Bx sessions. This is of importance when counseling AS patients. No adverse functional outcomes are expected if AS has to be discontinued and RP as curative option is contemplated. (c) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:91.e17 / 91.e22
页数:6
相关论文
共 50 条
  • [1] The Impact of Repeat Prostate Biopsies on Oncologic, Pathological and Perioperative Outcomes after Radical Prostatectomy
    Rosenbaum, Clemens M.
    Mandel, Philipp
    Tennstedt, Pierre
    Boehm, Katharina
    Chun, Felix K. -H.
    Graefen, Markus
    Heinzer, Hans
    Tilki, Derya
    Salomon, Georg
    JOURNAL OF UROLOGY, 2017, 197 (01) : 103 - 108
  • [2] Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols
    Anderson, Christopher B.
    Tin, Amy L.
    Sjoberg, Daniel D.
    Mulhall, John P.
    Sandhu, Jaspreet
    Touijer, Karim
    Laudone, Vincent P.
    Eastham, James A.
    Scardino, Peter T.
    Ehdaie, Behfar
    BJU INTERNATIONAL, 2016, 117 (6B) : E46 - E51
  • [3] Repeat prostate biopsies prior to radical prostatectomy do not impact erectile function recovery and mid- to long-term continence
    Furrer, Marc A.
    Vilaseca, Antoni
    Corradi, Renato B.
    Boxler, Silvan
    Thalmann, George N.
    Nguyen, Daniel P.
    PROSTATE, 2018, 78 (08) : 631 - 636
  • [4] Effect of metformin on prostate cancer outcomes after radical prostatectomy
    Kaushik, Dharam.
    Karnes, R. Jeffrey
    Eisenberg, Manuel. S.
    Rangel, Laureano J.
    Carlson, Rachel E.
    Bergstralh, Eric J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 43.e1 - 43.e7
  • [5] Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes
    Huelster, Heather L.
    Laviana, Aaron A.
    Joyce, Daniel D.
    Huang, Li-Ching
    Zhao, Zhiguo
    Koyama, Tatsuki
    Hoffman, Karen E.
    Conwill, Ralph
    Goodman, Michael
    Hamilton, Ann S.
    Wu, Xiao-Cheng
    Paddock, Lisa E.
    Stroup, Antoinette
    Cooperberg, Matthew
    Hashibe, Mia
    O'Neil, Brock B.
    Kaplan, Sherrie H.
    Greenfield, Sheldon
    Penson, David F.
    Barocas, Daniel A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 930.e23 - 930.e32
  • [6] Impact of Prostate Volume on Oncologic, Perioperative, and Functional Outcomes After Radical Prostatectomy
    Mandel, Philipp
    Weinhold, Philipp
    Michl, Uwe
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    PROSTATE, 2015, 75 (13) : 1436 - 1446
  • [7] The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy
    Mandel, Philipp
    Kretschmer, Alexander
    Chandrasekar, Thenappan
    Nguyen, Hao G.
    Buchner, Alexander
    Stief, Christian G.
    Tilki, Derya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (03) : 297 - 302
  • [8] Impact of Sarcopenia on Functional and Oncological Outcomes After Radical Prostatectomy
    Angerer, Markus
    Salomon, Georg
    Beyersdorff, Dirk
    Fisch, Margit
    Graefen, Markus
    Rosenbaum, Clemens M.
    FRONTIERS IN SURGERY, 2021, 7
  • [9] The influence of hepatic function on prostate cancer outcomes after radical prostatectomy
    Banez, L. L.
    Loftis, R. M.
    Freedland, S. J.
    Presti, J. C., Jr.
    Aronson, W. J.
    Amling, C. L.
    Kane, C. J.
    Terris, M. K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 173 - 177
  • [10] Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial
    Carlsson, Stefan
    Jaderling, Fredrik
    Wallerstedt, Anna
    Nyberg, Tommy
    Stranne, Johan
    Thorsteinsdottir, Thordis
    Carlsson, Sigrid V.
    Bjartell, Anders
    Hugosson, Jonas
    Haglind, Eva
    Steineck, Gunnar
    BJU INTERNATIONAL, 2016, 118 (02) : 205 - 212